Gene · 1814
Papers2,771
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,771
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Intra-individual variability of serum progesterone levels on the day of frozen blastocyst transfer in hormonal replacement therapy cycles. | Hum Reprod | 2024 | 38332539 | PubTator, text mining | PubMed |
| Cell-free DNA as a potential diagnostic biomarker in academic stress: A case-control study in young adults. | Saudi J Biol Sci | 2024 | 38304540 | PubTator, text mining | PubMed |
| Evidence Based Clinical Analytics Supporting the Genetic Addiction Risk Severity (GARS) Assessment to Early Identify Probands in Preaddiction. | EC Psychol Psychiatr | 2024 | 38298272 | PubTator, text mining | PubMed |
| Single nuclei transcriptomics in human and non-human primate striatum in opioid use disorder. | Nat Commun | 2024 | 38296993 | PubTator, text mining | PubMed |
| AKT2S128/CCTαS315/319/323-positive cancer-associated fibroblasts (CAFs) mediate focal adhesion kinase (FAK) inhibitors resistance via secreting phosphatidylcholines (PCs). | Signal Transduct Target Ther | 2024 | 38280862 | PubTator, text mining | PubMed |
| Long-Acting Injectable Second-Generation Antipsychotics in Seriously Ill Patients with Schizophrenia: Doses, Plasma Levels, and Treatment Outcomes. | Biomedicines | 2024 | 38255270 | PubTator, text mining | PubMed |
| Single Nucleotide Variants (SNVs) of the Mesocorticolimbic System Associated with Cardiovascular Diseases and Type 2 Diabetes: A Systematic Review. | Genes (Basel) | 2024 | 38254998 | PubTator, text mining | PubMed |
| The dopamine receptor D1 inhibitor, SKF83566, suppresses GBM stemness and invasion through the DRD1-c-Myc-UHRF1 interactions. | J Exp Clin Cancer Res | 2024 | 38246990 | PubTator, text mining | PubMed |
| Impaired cerebral microvascular endothelial cells integrity due to elevated dopamine in myasthenic model. | J Neuroinflammation | 2024 | 38178152 | PubTator, text mining | PubMed |
| Genetic risk scores associated with temperament clusters in Finnish depression patients. | Acta Neuropsychiatr | 2024 | 37665031 | PubTator, text mining | PubMed |
| Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson's Disease. | CNS Neurol Disord Drug Targets | 2024 | 36999711 | PubTator, text mining | PubMed |
| Exploring gene-drug interactions for personalized treatment of post-traumatic stress disorder. | Front Comput Neurosci | 2023 | 38274128 | PubTator, text mining | PubMed |
| Uncovering transcriptomic biomarkers for enhanced diagnosis of methamphetamine use disorder: a comprehensive review. | Front Psychiatry | 2023 | 38260797 | PubTator, text mining | PubMed |
| Machine learning techniques in diagnostics and prediction of the clinical features of schizophrenia: a narrative review. | Consort Psychiatr | 2023 | 38249535 | PubTator, text mining | PubMed |
| Editorial: Advanced biophysical and biochemical technologies to study GPCR signal transduction. | Front Endocrinol (Lausanne) | 2023 | 38239976 | PubTator, text mining | PubMed |
| Biomarkers of Affective Dysregulation Associated with In Utero Exposure to EtOH. | Cells | 2023 | 38201206 | PubTator, text mining | PubMed |
| Effectiveness of pharmacogenomics on the response and remission of treatment-resistant depression: a meta-analysis of randomised controlled trials. | Gen Psychiatr | 2023 | 38155841 | PubTator, text mining | PubMed |
| Mol-Zero-GAN: zero-shot adaptation of molecular generative adversarial network for specific protein targets. | RSC Adv | 2023 | 38090100 | PubTator, text mining | PubMed |
| Drug memory reconsolidation: from molecular mechanisms to the clinical context. | Transl Psychiatry | 2023 | 38040677 | PubTator, text mining | PubMed |
| Neuropathological features of levodopa-responsive parkinsonism in multiple system atrophy: an autopsy case report and comparative neuropathological study. | Front Neurol | 2023 | 38033780 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1814/papers?page=5